Holen Sie sich die Stockscreener-App
12.90
4.12%
0.51
Vorhandelsmarkt:
13.03
0.13
+1.01%
Schlusskurs vom Vortag:
$12.39
Offen:
$12.53
24-Stunden-Volumen:
1.67M
Relative Volume:
1.15
Marktkapitalisierung:
$963.90M
Einnahmen:
$255.87M
Nettoeinkommen (Verlust:
$-103.27M
KGV:
-9.1431
EPS:
-1.4109
Netto-Cashflow:
$12.46M
1W Leistung:
+9.88%
1M Leistung:
+11.40%
6M Leistung:
-35.47%
1J Leistung:
-48.99%
1-Tages-Spanne:
$12.52
$13.25
1-Wochen-Bereich:
$11.55
$13.25
52-Wochen-Spanne:
$10.95
$27.63
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, TEM, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
12.90 | 963.90M | 255.87M | -103.27M | 12.46M | -1.4109 |
VEEV
Veeva Systems Inc
|
170.22 | 27.80B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
53.54 | 10.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
55.81 | 10.01B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.18 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
24.89 | 4.60B | 637.78M | 239.40M | 307.21M | 1.1909 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Neutral |
| 2025-08-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-14 | Eingeleitet | Barclays | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
Here’s What the Street Thinks About Schrödinger (SDGR) - Insider Monkey
Schrödinger to Participate in Upcoming Investor Conferences - PharmiWeb.com
Liquidity Mapping Around (SDGR) Price Events - Stock Traders Daily
Schrödinger will webcast two healthcare conference talks in May - Stock Titan
MSN Money - MSN
Insider sales reported for SDGR (NASDAQ: SDGR) including 752/775/608 shares - Stock Titan
SDGR Stock Price, Quote & Chart | SCHRODINGER INC (NASDAQ:SDGR) - ChartMill
3.19M-share disclosure by Schrodinger (NASDAQ: SDGR) shows a 4.9% stake - Stock Titan
Earnings Preview: Schrodinger to Report Financial Results Post-market on May 05 - Moomoo
Vanguard Portfolio Management (SDGR) holds 3.91M shares, 6.04% stake - Stock Titan
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance
Schrodinger (SDGR) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Schrödinger Appoints Geoffrey Porges as Chief Financial Officer - Quantisnow
Form DEFA14A Schrodinger, Inc. - StreetInsider
[ARS] Schrodinger, Inc. SEC Filing - Stock Titan
Schrödinger (NASDAQ: SDGR) seeks approval for 3M-share equity plan increase - Stock Titan
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Quantisnow
Schrödinger updates 2025 software growth guidance to 8%-13% amid pharma scale-up delays and operational efficiency focus - MSN
Schrodinger downgraded at Citi after clinical program exit - MSN
Why (SDGR) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SDGR (Schrodinger Inc.) Q4 2025 EPS far outpaces consensus estimates, shares climb 2.32 percent.Fast Rising Picks - Xã Thanh Hà
Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 T - GuruFocus
Schrodinger: AI Threat Is Looming Large (Rating Downgrade) - Seeking Alpha
Schrodinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
SDGR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Schrödinger to Announce First Quarter 2026 Financial Results on May 5 - GuruFocus
Schrödinger’s impressive revenue growth justifies its high P/S ratio, fueling investor optimism and a bullish view on shares. A warning sign remains, signaling some risks persist despite positive outlooks. - Moomoo
Press Release: Schrödinger to Announce First Quarter 2026 Financial Results on May 5 - 富途牛牛
Craig-Hallum Remains a Buy on Schrodinger (SDGR) - The Globe and Mail
Schrodinger Inc (SDGR) Stock Up 3.6% and Still Undervalued -- GF Score: 71/100 - GuruFocus
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Schrodinger Inc Targets Software Contract Shift to Hosted Cloud Models - HarianBasis.co
What’s Schrodinger Inc (SDGR) Working Out with Anthropic? - Insider Monkey
How The Schrödinger (SDGR) Narrative Is Shifting With Hosted Software And Lower Price Targets - Yahoo Finance
Is Schrodinger (SDGR) stock failing to hold levels (Overhead Buying) 2026-04-18IPO Watch - Cổng thông tin điện tử tỉnh Lào Cai
Schrodinger (SDGR) Grants Stock Units to New Employees - GuruFocus
Schrodinger (NASDAQ:SDGR) CFO Rachit Jain Sells 844 Shares - MarketBeat
Ramy Farid Sells 43,000 Shares of Schrodinger (NASDAQ:SDGR) Stock - MarketBeat
Schrodinger CEO Farid Ramy sells $1m+ in shares By Investing.com - Investing.com Australia
Schrodinger EVP Rachit Jain sells $10,758 in shares By Investing.com - Investing.com India
Schrodinger EVP Rachit Jain sells $10,758 in shares - Investing.com
Schrodinger CEO Farid Ramy sells $1m+ in shares - Investing.com
Schrodinger (NASDAQ: SDGR) CFO sells 844 shares to cover RSU tax - Stock Titan
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.48%
7.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):